Wednesday, September 29, 9:00pm - 9:30pm (EDT)
Wednesday, September 29, 2021
6:00 pm (PT) / 7:00 pm (MT) / 8:00 pm (CT) / 9:00 pm (ET)
Article: Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis, N Engl J Med 2020; 383:2127-2137, DOI: 10.1056/NEJMoa2021713.
Download the article summary before the Twitter chat session at https://www.nationaljewish.org/ntmjournalclub
Faculty host: Charles L. Daley, MD, Chief, Division of Mycobacterial and Respiratory Infections, Professor of Medicine, University of Colorado Denver, National Jewish Healt, Denver, CO
To join the Twitter chat session:
•Log into your Twitter account and type the hashtag #NTMTwitterJC into the Search bar.
•Click on the “Latest” tab to see the discussion thread
•The discussion will start promptly at 6:00 pm (PT) / 7:00 pm (MT) / 8:00 pm (CT) / 9:00 pm (ET)
•Reply to Tweets about the article as they come in.
•Important: Remember to include the hashtag #NTMTwitterJC in every tweet during the session.
•Instructions for claiming CME credit will be posted at the end of the session
•Additionally, follow us on Twitter @NJHealthMedEd to learn about upcoming Journal Club article summaries/sessions and all of our CME offerings.
Supported by an Educational Grant from Insmed.
For further instructions on how to participate in the Twitter chat, visit https://www.nationaljewish.org/journalclubs.
For questions, contact the National Jewish Health Office of Professional Education at proed@njhealth.org or 303.398.1000.
Twitter #NTMTwitterJC
National Jewish Health Office of Professional Education, proed@njhealth.org